RP-64966

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameRP-64966
Drug Alias NameRP-64966
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHydrolases inhibitors
TargetsHydrolases
Therapy Area/IndicationsPsoriasisGoutArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRhone-Poulenc SA
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRhone-Poulenc SA
Active IndicationsN/A
Inactive IndicationsPsoriasisGoutArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A